DekaBank Deutsche Girozentrale - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 187 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$108,000
-51.6%
61,1000.0%0.00%
-100.0%
Q1 2022$223,000
-21.8%
61,100
+10.1%
0.00%0.0%
Q4 2021$285,000
-28.8%
55,500
+2.8%
0.00%0.0%
Q3 2021$400,000
-18.0%
54,0000.0%0.00%0.0%
Q2 2021$488,000
+2.5%
54,0000.0%0.00%
-50.0%
Q1 2021$476,000
-0.4%
54,0000.0%0.00%0.0%
Q4 2020$478,000
-24.5%
54,000
-4.4%
0.00%
-33.3%
Q3 2020$633,000
+904.8%
56,500
+89.0%
0.00%
Q3 2019$63,000
-64.0%
29,900
-50.0%
0.00%
-100.0%
Q2 2019$175,000
-4.9%
59,800
+64.3%
0.00%0.0%
Q1 2019$184,000
+55.9%
36,400
+21.7%
0.00%0.0%
Q4 2018$118,000
-35.9%
29,900
-17.9%
0.00%0.0%
Q3 2018$184,000
+26.9%
36,400
-2.7%
0.00%0.0%
Q2 2018$145,000
-17.6%
37,4000.0%0.00%0.0%
Q1 2018$176,000
-22.1%
37,400
-8.8%
0.00%
-50.0%
Q4 2017$226,0000.0%41,0000.0%0.00%0.0%
Q3 2017$226,000
-30.5%
41,0000.0%0.00%
-33.3%
Q2 2017$325,000
+21.3%
41,0000.0%0.00%
+50.0%
Q1 2017$268,000
-14.4%
41,000
-7.9%
0.00%
-33.3%
Q4 2016$313,000
-17.6%
44,500
+8.5%
0.00%
-25.0%
Q3 2016$380,000
-1.8%
41,0000.0%0.00%0.0%
Q2 2016$387,000
+47.1%
41,000
+34.4%
0.00%
+33.3%
Q1 2016$263,000
+2.7%
30,500
-16.4%
0.00%0.0%
Q4 2015$256,000
+23.1%
36,500
+1.4%
0.00%0.0%
Q3 2015$208,000
-24.9%
36,000
+5.9%
0.00%0.0%
Q2 2015$277,000
+18.9%
34,000
+19.3%
0.00%0.0%
Q1 2015$233,00028,5000.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders